» Articles » PMID: 36325824

Consistent Trajectories of Rhinitis Control and Treatment in 16,177 weeks: The MASK-air® Longitudinal Study

Abstract

Introduction: Data from mHealth apps can provide valuable information on rhinitis control and treatment patterns. However, in MASK-air®, these data have only been analyzed cross-sectionally, without considering the changes of symptoms over time. We analyzed data from MASK-air® longitudinally, clustering weeks according to reported rhinitis symptoms.

Methods: We analyzed MASK-air® data, assessing the weeks for which patients had answered a rhinitis daily questionnaire on all 7 days. We firstly used k-means clustering algorithms for longitudinal data to define clusters of weeks according to the trajectories of reported daily rhinitis symptoms. Clustering was applied separately for weeks when medication was reported or not. We compared obtained clusters on symptoms and rhinitis medication patterns. We then used the latent class mixture model to assess the robustness of results.

Results: We analyzed 113,239 days (16,177 complete weeks) from 2590 patients (mean age ± SD = 39.1 ± 13.7 years). The first clustering algorithm identified ten clusters among weeks with medication use: seven with low variability in rhinitis control during the week and three with highly-variable control. Clusters with poorly-controlled rhinitis displayed a higher frequency of rhinitis co-medication, a more frequent change of medication schemes and more pronounced seasonal patterns. Six clusters were identified in weeks when no rhinitis medication was used, displaying similar control patterns. The second clustering method provided similar results. Moreover, patients displayed consistent levels of rhinitis control, reporting several weeks with similar levels of control.

Conclusions: We identified 16 patterns of weekly rhinitis control. Co-medication and medication change schemes were common in uncontrolled weeks, reinforcing the hypothesis that patients treat themselves according to their symptoms.

Citing Articles

Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air.

Bousquet J, Sousa-Pinto B, Anto J, Bedbrook A, Czarlewski W, Ansotegui I Clin Transl Allergy. 2024; 14(9):e12390.

PMID: 39313483 PMC: 11419846. DOI: 10.1002/clt2.12390.


Action-plan and as-needed therapy in allergic rhinitis.

Yang H Clin Exp Pediatr. 2024; 67(6):267-273.

PMID: 38772413 PMC: 11150984. DOI: 10.3345/cep.2023.00654.


Asthma is associated with increased severity and duration of rhinitis: A study with the Allergic Rhinitis and its Impact on Asthma classes in the Constances cohort.

Savoure M, Bousquet J, Leynaert B, Ribet C, Goldberg M, Zins M Clin Transl Allergy. 2023; 13(11):e12316.

PMID: 38006378 PMC: 10668004. DOI: 10.1002/clt2.12316.


Daily allergy burden and heart rate characteristics in adults with allergic rhinitis based on a wearable telemonitoring system.

Buekers J, Stas M, Aerts R, Bruffaerts N, Dujardin S, Van Nieuwenhuyse A Clin Transl Allergy. 2023; 13(4):e12242.

PMID: 37186425 PMC: 10126716. DOI: 10.1002/clt2.12242.


Digital health for allergen immunotherapy.

Dramburg S, Matricardi P, Pfaar O, Klimek L Allergol Select. 2022; 6:293-298.

PMID: 36523960 PMC: 9746244. DOI: 10.5414/ALX02301E.